Global Generic Drug Alliance May Quit ICH Unless It Gets Seat On Steering Panel

The global generic drug trade lobby may pull out of the International Conference of Harmonisation unless it gets a seat on ICH's standards-setting steering committee, which issues quality guidelines that affect biosimilar and generic drug companies, the lobby group warns in an Aug. 8 letter to ICH. The International Generic Pharmaceutical Alliance is upset that ICH in a recent meeting decided to shut the generic drug industry out the steering committee, which includes regulators and brand-name drug industry officials from...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.